Shareholder alert: pomerantz law firm investigates claims on behalf of investors of praxis precision medicines, inc. - prax

New york, nov. 11, 2020 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of praxis precision medicines, inc. ("praxis" or the "company") (nasdaq: prax). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext....
PRAX Ratings Summary
PRAX Quant Ranking